Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,758 | -51,862 | -53,530 | -39,445 | -34,151 |
| Depreciation Amortization | -215 | 325 | 430 | 243 | 238 |
| Accounts receivable | -58 | -130 | 455 | 998 | -1,883 |
| Accounts payable and accrued liabilities | -856 | -2,225 | 1,485 | -3,829 | 6,037 |
| Other Working Capital | -5,213 | -3,955 | 8,077 | -4,896 | 7,623 |
| Other Operating Activity | 9,434 | 10,988 | 7,343 | 9,128 | 1,467 |
| Operating Cash Flow | $-51,666 | $-46,859 | $-35,740 | $-37,801 | $-20,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 51,315 | -6,611 | -62,288 | N/A | N/A |
| PPE Investments | -390 | -428 | -133 | -427 | -344 |
| Investing Cash Flow | $50,925 | $-7,039 | $-62,421 | $-427 | $-344 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 228 | 87,338 | 30,454 | 75,795 | 57,830 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 8,150 |
| Financing Cash Flow | $228 | $87,338 | $30,454 | $75,795 | $65,980 |
| Beginning Cash Position | 78,654 | 45,214 | 112,921 | 75,354 | 30,387 |
| End Cash Position | 78,141 | 78,654 | 45,214 | 112,921 | 75,354 |
| Net Cash Flow | $-513 | $33,440 | $-67,707 | $37,567 | $44,967 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,666 | -46,859 | -35,740 | -37,801 | -20,669 |
| Capital Expenditure | -390 | -428 | -133 | -427 | -344 |
| Free Cash Flow | -52,056 | -47,287 | -35,873 | -38,228 | -21,013 |